Table 1.

Characteristics and outcomes of the population in study.

Patient	Age (y)	BMI	Stage	Treatment	Comorbidities	Complications	Breast Q (2 years)	Physician assessment (2years)	Revision surgery	Follow-up (months)
1	50	25	pT2N1Mx	TER left+ MP right	None	–	91,5	Excellent	No	24
2	52	26,7	pT2N0Mx	TER left+ T right	None	–	89,6	Very good	Fat graft	24
3	50	26,5	pT2N1Mx	TER left+ MP right	None	–	87,5	Very good	No	24
4	58	32,4	pT1bN0Mx	TER right+ MP left	Hypertension Hypercholesterolemia	–	87,3	Very good	No	24
5	54	28,2	pT1bN1Mx	TER right+ MP left	Hypothyroidism	–	86,7	Very good	No	24
6	57	33,1	pT2N1Mx	TER right+ T left	Hypertension	Hypertrofic scars	79,2	Good	No	26
7	56	29,3	cT3N1Mx	TER right+ T left	None	–	83,8	Very good	No	26
8	56	28,7	pT2N1Mx	TER left+ T right	Hypertension	–	85,5	Very good	Fat graft	27
9	52	25,8	pT2N1Mx	TER left+ MP right	None	–	90,2	Excellent	No	30
10	55	25,7	pT1bN0Mx	TER right+ MP left	Hypercholesterolemia	–	89,8	Excellent	No	24
11	48	28,3	pT1bN0Mx	TER right+ T left	None	Hypertrofic scars	84,1	Very good	NO	26,3
12	54	27	pT2N1Mx	TER left+ MP right	None	–	85,6	Very good	No	28,5
13	49	27,9	pT2N1Mx	TER left+ MP right	Hypothyroidism	–	88,9	Very good	Fat graft	24
14	50	26,5	pT1bN1Mx	TER right+ T left	None	–	89	Excellent	No	24
15	53	25,5	pT2N1Mx	TER right+ T left	None	–	86	Excellent	No	24
16	57	33,1	pT2N0Mx	TER right+ T left	Hypertension Hypercholesterolemia	–	92,2	Good	Fat graft	26
17	56	32,6	pT2N0Mx	TER right+ T left	None	–	81,5	Good	No	29
18	47	26,9	pT1bN0Mx	TER left+ MP right	Hypothyroidism	–	89,2	Very good	No	28,5

TER: tissue expander replacement; MP: mastopexy; T: T-inverted breast reduction.